These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8971280)

  • 21. Hepatotoxicity of Inflammatory Bowel Disease Medications.
    Shamberg L; Vaziri H
    J Clin Gastroenterol; 2018 Sep; 52(8):674-684. PubMed ID: 30036242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in liver biochemistry during methotrexate use for inflammatory bowel disease.
    Fournier MR; Klein J; Minuk GY; Bernstein CN
    Am J Gastroenterol; 2010 Jul; 105(7):1620-6. PubMed ID: 20160715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Historical perspective on the use of methotrexate for the treatment of rheumatoid arthritis.
    Ward JR
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():3-6. PubMed ID: 3913774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to: "Methotrexate Use and Liver Outcomes in Psoriasis and Rheumatoid Arthritis Patients: A Commentary on 'Risk of liver disease in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis receiving methotrexate: A population-based study'".
    Gelfand JM; Syed MN
    J Am Acad Dermatol; 2021 Dec; 85(6):e401. PubMed ID: 34403717
    [No Abstract]   [Full Text] [Related]  

  • 25. Comment on: Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
    Lynch M; Kirby B
    Rheumatology (Oxford); 2010 Jan; 49(1):196-7; author reply 197-8. PubMed ID: 19858119
    [No Abstract]   [Full Text] [Related]  

  • 26. Methotrexate and other chemotherapeutic agents used to treat psoriasis.
    Jeffes EW; Weinstein GD
    Dermatol Clin; 1995 Oct; 13(4):875-90. PubMed ID: 8785891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis.
    Sharma A; Provenzale D; McKusick A; Kaplan MM
    Gastroenterology; 1994 Jul; 107(1):266-70. PubMed ID: 8020670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate in rheumatoid arthritis.
    Weinblatt ME; Kremer JM
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 1):126-8. PubMed ID: 3042815
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis.
    Weinstein GD; Cox JW; Suringa DW; Millard MM; Kalser M; Frost P
    Arch Dermatol; 1970 Dec; 102(6):613-8. PubMed ID: 5501902
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatotoxicity of long-term methotrexate therapy for psoriasis.
    Tobias H; Auerbach R
    Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020
    [No Abstract]   [Full Text] [Related]  

  • 31. Monitoring for methotrexate hepatotoxicity in patients with rheumatoid arthritis: another hepatologist's perspective.
    Lewis JH
    J Rheumatol; 1997 Aug; 24(8):1459-60. PubMed ID: 9263133
    [No Abstract]   [Full Text] [Related]  

  • 32. The risks of antimalarial retinopathy, azathioprine lymphoma and methotrexate hepatotoxicity during the treatment of rheumatoid arthritis.
    Urowitz MB; Lee P
    Baillieres Clin Rheumatol; 1990 Aug; 4(2):193-206. PubMed ID: 2032296
    [No Abstract]   [Full Text] [Related]  

  • 33. Massive intrahepatic hemorrhage following routine liver biopsy in a patient with rheumatoid arthritis treated with methotrexate.
    Cash JM; Swain M; Di Bisceglie AM; Wilder RL; Crofford LJ
    J Rheumatol; 1992 Sep; 19(9):1466-8. PubMed ID: 1433018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Creating a care-effective cost-effective strategy for methotrexate liver toxicity monitoring in rheumatoid arthritis: comment on the article by Kremer et al.
    Newman ED; Harrington TM; Perruquet JL; Davis DE; Torretti D
    Arthritis Rheum; 1995 Feb; 38(2):297-8. PubMed ID: 7848325
    [No Abstract]   [Full Text] [Related]  

  • 35. Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials.
    Conway R; Low C; Coughlan RJ; O'Donnell MJ; Carey JJ
    BMJ; 2015 Mar; 350():h1269. PubMed ID: 25770113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic.
    Mor A; Bingham CO; Kishimoto M; Izmirly PM; Greenberg JD; Reddy S; Rosenthal PB
    Ann Rheum Dis; 2008 Apr; 67(4):462-5. PubMed ID: 17711866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suggested guidelines for monitoring liver toxicity in rheumatoid arthritis patients treated with methotrexate: comment on the article by Kremer et al.
    Fries JF; Ramey DR; Singh G
    Arthritis Rheum; 1994 Dec; 37(12):1829-30. PubMed ID: 7986233
    [No Abstract]   [Full Text] [Related]  

  • 38. [Guidelines on the use of methotrexate in psoriasis].
    Carretero G; Puig L; Dehesa L; Carrascosa JM; Ribera M; Sánchez-Regaña M; Daudén E; Vidal D; Alsina M; Muñoz-Santos C; López-Estebaranz JL; Notario J; Ferrandiz C; Vanaclocha F; García-Bustinduy M; Taberner R; Belinchón I; Sánchez-Carazo J; Moreno JC;
    Actas Dermosifiliogr; 2010 Sep; 101(7):600-13. PubMed ID: 20858386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose methotrexate treatment of rheumatoid arthritis. Long-term observations.
    Weinstein A; Marlowe S; Korn J; Farouhar F
    Am J Med; 1985 Sep; 79(3):331-7. PubMed ID: 4036984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate in rheumatoid arthritis.
    Furst DE; Kremer JM
    Arthritis Rheum; 1988 Mar; 31(3):305-14. PubMed ID: 2965875
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.